COMPANY PROFILE · UPDATED 18 NOV 2025

CASI Pharmaceuticals

A biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients.

casipharmaceuticals.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 1991
Headcount: 49
Open roles: 0
Last raised: Post Ipo Equity · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Roles at CASI Pharmaceuticals

Employbl doesn’t track CASI Pharmaceuticals’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING

Capital raised

Total raised

$200,380,000

Investors

Accel ETP Fund Emerging Technology Partners Foresite Capital GE Healthcare Systems IDG Capital Merrill Lynch Oxford Finance Panacea Venture Robert Duggan Venrock Healthcare Capital Partners Wei-Wu He

Funding rounds

Post Ipo Equity
Diffbot knowledge graph
Foresite Capital, Venrock Healthcare Capital Partners, Wei-Wu He, Panacea Venture
$15MJun 25, 2024
Post Ipo Equity
Diffbot knowledge graph
$32.5MMar 23, 2021
Post Ipo Equity
Diffbot knowledge graph
$38MJul 21, 2020
Post Ipo Equity
Diffbot knowledge graph
IDG Capital, ETP Fund, Robert Duggan
$50MMar 19, 2018
Post Ipo Equity
Diffbot knowledge graph
$2.4MOct 15, 2017
IPO
Diffbot knowledge graph
UndisclosedJan 1, 2014
Post Ipo Equity
Diffbot knowledge graph
Accel, Emerging Technology Partners
$10MJan 22, 2012
Post Ipo Equity
Diffbot knowledge graph
$2.5MFeb 3, 2010
Post Ipo Debt
Diffbot knowledge graph
GE Healthcare Systems, Merrill Lynch, Oxford Finance
$20MSep 16, 2007
Post Ipo Equity
Diffbot knowledge graph
$30MFeb 12, 2006